{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:22:56Z","timestamp":1761549776061,"version":"build-2065373602"},"reference-count":37,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["openrheumatologyjournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TORJ"],"published-print":{"date-parts":[[2010,8,1]]},"abstract":"\n Abstract<\/jats:title>\n \n Objective:<\/jats:title>\n Rheumatic fever (RF) is well known disease as a result of frequent complication of the group A- b hemolytic streptococcal (GABHS) tonsillopharyngitis, have noticeably grown for the last 15 years among young generation in the Kyrgyz Republic. It is important to hold a study about the prevalence of RF and GABHS and their susceptibility to antibiotics in the Kyrgyz Republic.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n We have studied 200 children with chronic tonsillopharyngitis at the National Center of Pediatrics and Child Surgery in Bishkek (the Kyrgyz Republic) from August till September 2008. 188 (48 out of them are with RF) out of total 200 children are Kyrgyz and 12 are Russian (2 out of them are with RF). 111 out of total are female (34 out of them are with RF) and 89 are male (17 out of them are with RF). The average age of the subjects is 10.9\u00b16.0 (from 3 to 17 years old). The presence of GABHS was assessed using two ways: by the rapid antigen detection test (RADT) for outcrop of streptococcus antigen in smear from mucosal surface of tonsils, and by bacterial culture analysis (BA). RADT was used to determine its specificity and sensitivity in order to recommend practitioners its further wide use. Furthermore, the discovered culture of GABHS have been investigated on susceptibility to antibiotics by disc-diffusion method.<\/jats:p>\n <\/jats:sec>\n \n Research Results:<\/jats:title>\n GABHS antigen was positive in 72 (36.0 %) subjects from RADT and in 80 (40.0%) subjects from BA out of 200 total subjects. In the patients with RF (n=51), GABHS was positive in 18 (35.2%) subjects by RADT and in 24 (47.0%) subjects by BA. In the subjects without RF (n=149), GABHS was positive in 54 (36.2%) subjects by RADT and in 56 (37.5%) by BA. Among 80 GABHS positive results sensitive to antibiotics were: to penicillin only 10 (12.5%), to ampicillin-29 (36.2%), to amoxicillin-36 (45.0%), to ceftriaxon - 31 (38.7%), to roxithromycin - 21 (26.2%), to erythromycin- 19 (23.7%). It is noted that 21 (26.2%) GABHS positive results were absolutely resistant for all these tested antibiotics. RADT showed that its specificity is 85% as well as its sensitivity is equal to 67.5%.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n In this study the sensitivity of RADT was low; therefore, the negative results of RADT don\u2019t exclude presence of GABHS. High prevalence of GABHS antigen demonstrates not only in patients with RF, but also among healthy children (without RF) of the Kyrgyz Republic. The high prevalence of GABHS at children with RF (47.0%), probably, presents a low sensitivity to antibiotics and irregular secondary prophylaxis. Significant presence of GABHS among healthy children (37.5%) requires improvement of primary prevention to prevent further spread of RF and Rheumatic Heart Disease (RHD) in the country.<\/jats:p>\n <\/jats:sec>\n <\/jats:sec>","DOI":"10.2174\/1874312901004010039","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T05:59:12Z","timestamp":1431583152000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of Group A b-Hemolytic Streptococcus Among Children with Tonsillopharyngitis in Kyrgyzstan: The Difficulty of Diagnostics and Therapy"],"prefix":"10.2174","volume":"4","author":[{"given":"Nazgul A","family":"Omurzakova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guli M","family":"Saatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayramkan S","family":"Alybaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kusuki","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1756-185X.2009.01388.x","volume":"12","author":"Omurzakova NA","year":"2009","unstructured":"Omurzakova NA, Yoshihisa Y, Saatova GM, et al. \n High incidence of rheumatic fever and rheumatic heart disease in republics of Central Asia \n Int J Rheum Dis \n 2009; \n 12\n : 79-83.","journal-title":"Int J Rheum Dis"},{"key":"refR2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"Carapetis JR","year":"2005","unstructured":"Carapetis JR, Steer AC, Mulholland EK, et al. \n The global burden of group A streptococcal diseases \n Lancet Infect Dis \n 2005; \n 5\n : 685-94.","journal-title":"Lancet Infect Dis"},{"key":"refR3","unstructured":"Atlas of Heart Diseases and Stroke \n Available from URL: http:\/\/www.who.int\/cardivascular_diseases\/resources\/atlas\/en\/Rheumaticfeverandrheumaticheartdisease \n 2004."},{"journal-title":"Geneva","year":"2001","key":"refR4","unstructured":"Rheumatic fever and RHD.Report of a WHO Expert Consultation \n Geneva \n 2001."},{"key":"refR5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp078039","volume":"357","author":"Jonathan R","year":"2007","unstructured":"Jonathan R. \n Carapetis rheumatic heart disease in developing countries \n N Engl J Med \n 2007; \n 357\n : 439-1.","journal-title":"N Engl J Med"},{"key":"refR6","first-page":"1","volume":"923","year":"2004","unstructured":"Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation \n World Health Organ Tech Rep Ser \n 2004; \n 923\n : 1-122.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"refR7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1253\/jcj.50.1241","volume":"50","author":"Kawakita S","year":"1986","unstructured":"Kawakita S. \n Rheumatic fever and rheumatic heart disease in Japan \n Jpn Circ J \n 1986; \n 50\n (12)\n : 1241-45.","journal-title":"Jpn Circ J"},{"key":"refR8","first-page":"S1","volume":"55","author":"Brook I","year":"2006","unstructured":"Brook I, Dohar JE. \n Management of group A beta-hemolytic streptococcal pharyngotonsillitis in children \n J Fam Pract \n 2006; \n 55\n (12)\n : S1-11.","journal-title":"J Fam Pract"},{"key":"refR9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0196-0644(95)70300-4","volume":"25","author":"Pichicheri ME","year":"1995","unstructured":"Pichicheri ME. \n Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatament \n Ann Emerg Med \n 1995; \n 25\n : 390-403.","journal-title":"Ann Emerg Med"},{"key":"refR10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1590\/S0034-72992006000500003","volume":"72","author":"Vieira FM","year":"2006","unstructured":"Vieira FM, Figueiredo CR, Soares MC, et al. \n Prevalence of Streptococcus pyogenes as an oropharynx colonizer in children attending daycare: a comparative study of different regions in Brazil \n Rev Bras Otorrinolaringol \n 2006; \n 72\n (5)\n : 587-91.","journal-title":"Rev Bras Otorrinolaringol"},{"key":"refR11","first-page":"869","volume":"1","author":"Omurzakova NA","year":"2008","unstructured":"Omurzakova NA, Yoshihisa Y, Tomoo S, et al. \n Increased prevalence of group A b-hemolytic streptococcus among an ethnic population in Kyrgyzstan detected by the rapid antigen detection test \n Mol Med Report \n 2008; \n 1\n : 869-74.","journal-title":"Mol Med Report"},{"key":"refR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/340949","volume":"15","author":"Bisno AL","year":"2002","unstructured":"Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. \n Infectious Diseases Society of America. \n Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis \n Clin Infect Dis \n 2002; \n 15\n : 113-25.","journal-title":"Clin Infect Dis"},{"journal-title":"Geneva: WHO","year":"1991","key":"refR13","unstructured":"WHO. \n Basic laboratory procedures in clinical bacteriology \n Geneva: WHO \n 1991."},{"journal-title":"Geneva: WHO","year":"2003","key":"refR14","unstructured":"WHO. \n Basic laboratory procedures in clinical bacteriology \n Geneva: WHO 2. \n 2003."},{"key":"refR15","first-page":"p. N1","volume":"vol. 19","year":"1999","unstructured":"National committee on clinical laboratory standards.performance standards for antimicrobial susceptibility testing \n Ninth Informational Supplement M100-S9 USA: NCCLS \n 1999; \n vol. 19\n : p. N1.","journal-title":"Ninth Informational Supplement M100-S9. USA: NCCLS"},{"journal-title":"Pennsylania.USA, CLSI, Wayne","year":"2005","key":"refR16","unstructured":"Clinical laboratory standards institute: performance standards for antimicrobial susceptibility testing: seventh informational supplement M100-S15 \n PennsylaniaUSA, CLSI, Wayne \n 2005."},{"key":"refR17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(03)00576-0","volume":"3","author":"Bisno AL","year":"2003","unstructured":"Bisno AL, Brito MO, Collins CM. \n Molecular basis of group A streptococcal virulence \n Lancet Infect Dis \n 2003; \n 3\n : 191-200.","journal-title":"Lancet Infect Dis"},{"key":"refR18","unstructured":"Allan G, John BZ. \n \n\n Rheumatic fever: etiology, diagnosis, and treatment.\/\/ Arthritis and allied conditions In: William J Koopman, Ed. \n A textbook of RheumatologyVolume 2. 14. \n 2001; 1486: pp. \n \n \n 1761-73."},{"key":"refR19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0140-6736(90)92777-F","volume":"336","author":"Schwartz B","year":"1990","unstructured":"Schwartz B, Facklam RR, Breiman RF. \n Changing epidemiology of streptococcal infection in the USA \n Lancet \n 1990; \n 336\n : 1167-71.","journal-title":"Lancet"},{"key":"refR20","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/01.CIR.88.4.1964","volume":"88","author":"Kaplan EL","year":"1993","unstructured":"Kaplan EL. \n Global assessment of rheumatic fever and rheumatic heart disease at the clouse of the century.influences and dynamics of populations and pathogens: a failure to realize prevention? \n Circulation \n 1993; \n 88\n : 1964-72.","journal-title":"Circulation"},{"key":"refR21","first-page":"9","volume":"14","author":"Kawakami S","year":"2003","unstructured":"Kawakami S, Ono Y, Yanagawa Y, Miyazawa Y. \n Basic and clinical evaluation of the new rapid diagnostic kit for detecting group A streptococci with the immunochromatographical method \n Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi \n 2003; \n 14\n (1)\n : 9-16.","journal-title":"Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi"},{"key":"refR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/emj.2004.022970","volume":"23","author":"Van Limbergen J","year":"2006","unstructured":"Van Limbergen J, Kalima P, Taheri S, Beattie TF. \n Streptococcus A in pediatric accident and emergency: are rapid streptococcal tests and clinical examination of any help? \n Emerg Med J \n 2006; \n 23\n (1 )\n : 32-4.","journal-title":"Emerg Med J"},{"key":"refR23","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/jama.1981.03320160022023","volume":"246","author":"Schwartz RH","year":"1981","unstructured":"Schwartz RH, Wientzen RL, Pedreira F, et al. \n Penicillin V for Group A streptococcal pharyngotonsillitis.A randomized triel of seven vs ten days therapy \n JAMA \n 1981; \n 246\n : 1790-95.","journal-title":"JAMA"},{"key":"refR24","first-page":"224","volume":"141","author":"Gerber MA","year":"1987","unstructured":"Gerber MA, Randolph MF, Chanatry J, et al. \n Five days versus ten days of penicillin therapy for streptococcal pharyngitis \n Am J Dis Child \n 1987; \n 141\n : 224-7.","journal-title":"Am J Dis Child"},{"key":"refR25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00006454-199608000-00008","volume":"15","author":"Cohen R","year":"1996","unstructured":"Cohen R, Levy K, Doit C, et al. \n Six-day amoxicillin vs ten day penicillin V therapy for group A streptococcal tonsillopharyngitis \n Pediatr Infect Dis J \n 1996; \n 15\n (8 )\n : 678-82.","journal-title":"Pediatr Infect Dis J"},{"key":"refR26","first-page":"E191","volume":"105","author":"Lan AJ","year":"2000","unstructured":"Lan AJ, Colford JM. \n The impact of dosing frequency in the efficacy of 10-day penicillin or amoxicillin therapy for streptococcal tonsillopharyngitis: a meta-analysis \n Pediatrics \n 2000; \n 105\n (2)\n : E191-201.","journal-title":"Pediatrics"},{"key":"refR27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1159\/000238617","volume":"34","author":"Randolph MF","year":"1988","unstructured":"Randolph MF. \n Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis \n Chemotherapy \n 1988; \n 34\n : 512-18.","journal-title":"Chemotherapy"},{"key":"refR28","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0022-3476(86)80139-1","volume":"109","author":"Gerber MA","year":"1986","unstructured":"Gerber MA, Randolph MF, Chanatry J, et al. \n Once-daily therapy for streptococcal pharyngitis with cefadroxil \n J Pediatr \n 1986; \n 109\n : S31-7.","journal-title":"J Pediatr"},{"key":"refR29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/AAC.44.6.1453-1457.2000","volume":"44","author":"Bingen E","year":"2000","unstructured":"Bingen E, Fitoussi F, Doit C, Cohen R, et al. \n Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients \n Antimicrob Agents Chemother \n 2000; \n 44\n (6)\n : 1453-57.","journal-title":"Antimicrob Agents Chemother"},{"key":"refR30","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/00006454-199110001-00015","volume":"10","author":"Holm SE","year":"1991","unstructured":"Holm SE, Roos K, Stromberg A. \n A randomised study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V) \n Pediatr Infect Dis J \n 1991; \n 10\n : S68-71.","journal-title":"Pediatr Infect Dis J"},{"key":"refR31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/bmj.306.6886.1170","volume":"306","author":"Shvartzman P","year":"1993","unstructured":"Shvartzman P, Tabenkin H, Rosentzwaig A, et al. \n Treatment of streptococcal pharyngitis with amoxicillin once a day \n Br Med J \n 1993; \n 306\n (6886)\n : 1170-3.","journal-title":"Br Med J"},{"key":"refR32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/37.1.133","volume":"37","author":"Dykhuizen RS","year":"1996","unstructured":"Dykhuizen RS, Golder D, Reid TMS, et al. \n Phenoxymethyl-penicillin versus co-amoxiclav in treatment of acute streptococcal pharyngitis and the role of beta-lactamase activity in saliva \n J Antimicrob Chemother \n 1996; \n 37\n (1)\n : 133-8.","journal-title":"J Antimicrob Chemother"},{"key":"refR33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/00365549609037947","volume":"28","author":"Peyramond D","year":"1996","unstructured":"Peyramond D, Portier H, Geslin P, Cohen R. \n 6 - day amoxicillin versus 10 - day penicillin V for group A B-haemolitic streptococcal acute tonsillitis in adults: A French multicentre, open - label, randomized study \n Scand J Infect Dis \n 1996; \n 28\n (5)\n : 497-01.","journal-title":"Scand J Infect Dis"},{"key":"refR34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/24.2.227","volume":"24","author":"Brook I","year":"1989","unstructured":"Brook I. \n Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic Streptococci a prospective randomized study comparing penicillin and amoxicillin\/clavulanate potassium J \n Antimicrob Chemother \n 1989; \n 24\n (2)\n : 227-33.","journal-title":"Antimicrob Chemother"},{"key":"refR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/27.suppl_A.75","volume":"27","author":"Bachand RTJr","year":"1991","unstructured":"Bachand RTJr. \n A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis \n J Antimicrob Chemother \n 1991; \n 27 \n ((Suppl A))\n : 75-82.","journal-title":"J Antimicrob Chemother"},{"key":"refR36","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1086\/320745","volume":"32","author":"Kaplan EL","year":"2001","unstructured":"Kaplan EL, Gooch WM III, Notario GF, Craft JC. \n Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective than 5 days (azithro-mycin) \n Clin Infect Dis \n 2001; \n 32\n : 1798-02.","journal-title":"Clin Infect Dis"},{"key":"refR37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2165\/00044011-199713060-00006","volume":"13","author":"Gendrel D","year":"1997","unstructured":"Gendrel D, Bourrillon A, Bingen E, et al. \n Five-day spiramycin vs seven-day penicillin V in the treatment of streptococcal tonsillitis in children \n Clin Drug Invest \n 1997; \n 13\n (6)\n : 338-44.","journal-title":"Clin Drug Invest"}],"container-title":["The Open Rheumatology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openrheumatologyjournal.com\/contents\/volumes\/V4\/TORJ-4-39\/TORJ-4-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openrheumatologyjournal.com\/contents\/volumes\/V4\/TORJ-4-39\/TORJ-4-39.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openrheumatologyjournal.com\/contents\/volumes\/V4\/TORJ-4-39\/TORJ-4-39.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:20:06Z","timestamp":1761549606000},"score":1,"resource":{"primary":{"URL":"https:\/\/openrheumatologyjournal.com\/VOLUME\/4\/PAGE\/39\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,8,1]]}},"alternative-id":["TORJ-4-39"],"URL":"https:\/\/doi.org\/10.2174\/1874312901004010039","relation":{},"ISSN":["1874-3129"],"issn-type":[{"type":"print","value":"1874-3129"}],"subject":[],"published":{"date-parts":[[2010,8,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2010-05-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-07-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-07-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}